Cheol Whan Lee, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. QCA Guidance with Selective Use of IVUS Is a Reasonable Approach in Contemporary PCI.
  2. [Debate I: How to Do PCI?] QCA-Guidance Is Enough.
  3. PCI vs. CABG for Left Main or Multivessel CAD: Evolution and Current Status
  4. Future Trials - PCI vs. CABG: MVD, Ischemic Heart Failure / - QCA vs. Imaging Guidance: Guide BVS Trial / - Metal vs. Polymer Jackets: BVS Long Trial
  5. Stents vs. Surgery for Left Main or Multivessel CAD: Insights from a Patient-Level Meta-Analysis
  6. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data
  7. Revascularization in Multivessel CAD: Full Database Analysis
  8. PCI vs. CABG for Left Main or Multivessel CAD: Evolution and Current Status
  9. More Than Twelve Months!
  10. How Long DAPT Now?
  11. AMC Experience: Temporal Patterns of DES Failure & Relation to Outcomes
  12. Vascular Healthcare: Focused on Evolving Issues
  13. Aspirin on Top of P2Y12 Inhibitors: Little Benefit, Possible Harm
  14. Dual Therapy After DES Implantation: DES LATE and More
  15. P2Y12 Receptor Blockers: Which Drug (Clopidogrel, Prasugrel, and Ticagrelor) and for Whom?
  16. Plaque Profiling: Pursing VP Signatures & New Therapeutic Agents
  17. Plaque Profilings: Insights from the Culprit Plaques
  18. Insights into Antiplatelet Therapy: From CAPRIE to TRITON-TIMI 38
  19. CiloTax: New Generation Drug-Eluting Stent
  20. Regression: An Evidence-Based Assessment
  21. Dual Antiplatelet Therapy: How Long Should It Be Continued after DES Implantation?
  22. Early Statin Therapy in Acute Coronary Syndrome
  23. The New NCEP III Guidelines: A Clinical Challenge to Interventional Cardiologists for Wider Utilization of Statins
  24. Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy